Product design: A nanomized nutraceutical with enhanced bioactivity and bioavailability

Industrial and Engineering Chemistry Research

Volumn 51, Issue 21, 2012, Pages 7320-7326

  Lau, Yeuk Tin ^a   Chen, Na ^b   Ko, Kam Ming ^b   Ng, Ka Ming ^c  

^a Division of Life Science   (Hong Kong)

^b Division of Life Science   (Hong Kong)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL STUDIES; AVERAGE SIZE; GLUTATHIONES; IN-VIVO; MODEL COMPOUND; MODEL DRUGS; NANOEMULSION; NUTRACEUTICALS; ORANGE OIL; PROCESS DEVELOPMENT; PROCESSING CONDITION; PRODUCT ATTRIBUTES; PRODUCT FORMULATION; PRODUCT QUALITY; REGENERATION CAPACITY; SCHISANDRIN; TWO-PRODUCT;

BIOACTIVITY; PARTICLE SIZE;

PRODUCT DESIGN;

EID: 84866949688     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/ie201886p     Document Type: Article

References (32)

1. Lipinski, C. A Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 2002, 5, 82.
2. Merisko-Liversidge, E.; Liversidge, G. G.; Cooper, E. R. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 2003, 18, 113.
3. Keck, C. M.; Muller, R H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur. J. Pharm. Sci. 2006, 62, 3.
4. Kesisoglou, F.; Panmai, S.; Wu, Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Delivery Rev. 2007, 59, 631.
5. Gutierrez, J. M.; Gonzalez, C.; Maestro, A.; Sole, I.; Pey, C. M.; Nolla, J. Nano-emulsions: New applications and optimization of their preparation. Curr. Opin. Colloid Interface Sci. 2008, 13, 245.
6. Muller, R. H.; Becker, R.; Kruss, B.; Peters, K Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution. U.S. Patent 5, 858, 410, January 12, 1999.
7. Cooper, A.; Butler, R Porous material and method of production thereof. International Patent WO 2005/014, 704 A1, 2005.
8. Liversidge, G G; Cundy, K C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 1995, 125, 91.
9. Kayser, O.; Olbrich, C.; Yardley, V.; Kiderlen, A. F.; Croft, S. L. Formulation of amphotericin B as nanosuspension for oral administration. Int. J. Pharm. 2003, 254, 73.
10. Bisht, S.; Feldmann, G; Soni, S.; Ravi, R; Karikar, C.; Maitra, A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy. J. Nanobiotechnol. 2007, 5, 3.
11. Voncken, R M.; Broekhuis, A. A; Heeres, H. J.; Jonker, G. H. The many facets of product technology. Chem. Eng. Res. Des. 2004, 82, 1411.
12. Whitnack, C.; Heller, A; Frow, M. T.; Kerr, S.; Bagajewicz, M.J. Financial risk management in the design of products under uncertainty. Comput. Chem. Eng. 2009, 33, 1056.
13. Street, C.; Woody, J.; Ardila, J.; Bagajewicz, M. Product design: A case study of slow-release carpet deodorizers/disinfectants. Ind. Eng. Chem. Res. 2008, 47, 1192.
14. Marquardt, W.; Harwardt, A.; Hechinger, M.; Kraemer, K; Viell, J.; Voll, A. The biorenewables opportunity-toward next generation process and product systems. AIChE J. 2010, 56, 2228.
15. Hechinger, M.; Voll, A; Marquardt, W. Towards an integrated design of biofuels and their production pathways. Comput. Chem. Eng. 2010, 34, 1909.
16. Fung, K. Y.; Kwong, C. K; Siu, K. W. M.; Yu, K. M. A multi-objective genetic algorithm approach to rule mining for affective product design. Expert Syst. Appl. 2012, 39, 7411.
17. Conte, E.; Gani, R; Ng, K M. Design of formulated products: A systematic methodology. AIChE J. 2011, 57, 2431.
18. Conte, E.; Gani, R; Cheng, Y. S.; Ng, K M. Design of formulated products: Experimental component. AIChE J. 2012, 58, 173.
19. Cheng, Y. S.; Lam, K W.; Ng, K M.; Ko, K M.; Wibowo, C. An integrative approach for product development-a skin-care cream. Comput. Chem. Eng. 2009, 33, 1097.
20. Cheng, Y. S.; Ng, K M.; Wibowo, C. Product design: A transdermal patch containing a TCM tincture. Ind. Eng. Chem. Res. 2010, 49, 4904.
21. Ip, S. P.; Poon, M. K. T.; Wu, S. S.; Che, C. T.; Ng, K. H.; Kong, Y. C.; Ko, K. M. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: Protection against carbon tetrachloride toxicity. Planta Med. 1995, 61, 398.
22. Floury, J.; Legrand, J.; Desrumaux, A. Analysis of a new type of high pressure homogenizer. Part B. study of droplet break-up and recoalescence phenomena. Chem. Eng. Sci. 2004, 59, 1285.
23. Perrier-Cornet, J. M.; Marie, P.; Gervais, P. Comparison of emulsification efficiency of protein-stabilized oil-in-water emulsions using jet, high pressure and colloid mill homogenization. J. Food Eng. 2005, 66, 211.
24. Tesch, S.; Schubert, H. Influence of increasing viscosity of the aqueous phase on the short-term stability of protein stabilized emulsions. J. Food Eng. 2002, 52, 305.
25. Schultz, S.; Wagner, G; Urban, K; Ulrich, J. High-pressure homogenization as a process for emulsion formation. Chem. Eng. Technol. 2004, 27, 361.
26. Chiu, P. Y.; Ko, K M. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. BioFactors 2003, 19, 43.
27. Yim, T. K; Ko, K M. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Mol. Cell. Biochem. 1999, 196, 151.
28. Ko, K M.; Mak, H. F.; Li, P. C.; Poon, K. T.; Ip, S. P. Enhancement of hepatic glutathione regeneration capacity by a lignan-enriched extract of fructus schisandrae in rats. Jpn. J. Pharmacol. 1995, 69, 439.
29. Sies, H; Summer, K H. Hydroperoxide-metabolizing systems in rat liver. Eur. J. Biochem. 1975, 57, 503.
30. Sies, H; Gersterecker, C.; Menzel, H.; Flohe, L. Oxidation in the NADPH system and release of GSSG from hemoglobin free perfused rat liver during peroxidatic oxidation of glutathione by hydroperoxide. FEBS Lett. 1972, 27, 171.
31. Harjo, B.; Wibowo, C.; Zhang, E. J. N; Luo, K Q.; Ng, K M. Development of process alternatives for separation and purification of isoflavones. Ind. Eng. Chem. Res. 2007, 46, 181.
32. Zhang, E. J. N; Ng, K M.; Luo, K Q. Extraction and purification of isoflavones from soybeans and characterization of their estrogenic activities. J. Agric. Food Chem. 2007, 55, 6940.